Skip NavigationSkip to Content

Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

  1. Author:
    Lifson, J. D.
    Rossio, J. L.
    Piatak, M.
    Parks, T.
    Li, L.
    Kiser, R.
    Coalter, V.
    Fisher, B.
    Flynn, B. M.
    Czajak, S.
    Hirsch, V. M.
    Reimann, K. A.
    Schmitz, J. E.
    Ghrayeb, J.
    Bischofberger, N.
    Nowak, M. A.
    Desrosiers, R. C.
    Wodarz, D.
  2. Author Address

    NCI, Retroviral Pathogenesis Lab, AIDS Vaccine Program, SAIC Frederick, Bldg 535, 5th Floor, Ft Detrick, MD 21702 USA. NCI, Retroviral Pathogenesis Lab, AIDS Vaccine Program, SAIC Frederick, Ft Detrick, MD 21702 USA. NCI, Vaccine Support Lab, AIDS Vaccine Program, SAIC Frederick, Ft Detrick, MD 21702 USA. NCI, Anim Sci Branch, Bethesda, MD 20892 USA. Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Southborough, MA 01772 USA. NIAID, Mol Microbiol Lab, NIH, Rockville, MD 20852 USA. Centocor Inc, Malvern, PA 19355 USA. Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA. Gilead Sci Inc, Foster City, CA 94404 USA. Inst Adv Study, Program Theoret Biol, Princeton, NJ 08540 USA. Lifson JD NCI, Retroviral Pathogenesis Lab, AIDS Vaccine Program, SAIC Frederick, Bldg 535, 5th Floor, Ft Detrick, MD 21702 USA.
    1. Year: 2001
  1. Journal: Journal of Virology
    1. 75
    2. 21
    3. Pages: 10187-10199
  2. Type of Article: Article
  1. Abstract:

    Transient antiretroviral treatment with tenofovir, (R)-9-(2- phosphonylmethoxypropyl) adenine, begun shortly after inoculation of rhesus macaques with the highly pathogenic simian immunodeficiency virus (SIV) isolate SIVsmE660, facilitated the development of SIV-specific lymphoproliferative responses and sustained effective control of the infection following drug dis continuation. Animals that controlled plasma viremia following transient postinoculation treatment showed substantial resistance to subsequent intravenous rechallenge with homologous (SIVsmE660) and highly heterologous (SIVmac239) SIV isolates, up to more than 1 year later, despite the absence of measurable neutralizing antibody. In some instances, resistance to rechallenge was observed despite the absence of detectable SIV-specific binding antibody and in the face of SIV lymphoproliferative responses that were low or undetectable at the time of challenge. In vivo monoclonal antibody depletion experiments demonstrated a critical role for CD8(+) lymphocytes in the control of viral replication; plasma viremia rose by as much as five log units after depletion of CD8(+) cells and returned to predepletion levels (as low as <100 copy Eq/ml) as circulating CD8(+) cells were restored. The extent of host control of replication of highly pathogenic SIV strains and the level of resistance to heterologous rechallenge achieved following transient postinoculation treatment compared favorably to the results seen after SIVsmE660 and SIVmac239 challenge with many vaccine strategies. This impressive control of viral replication was observed despite comparatively modest measured immune responses, less than those often achieved with vaccination regimens. The results help establish the underlying feasibility of efforts to develop vaccines for the prevention of AIDS, although the exact nature of the protective host responses involved remains to be elucidated.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel